- Home
- EBF vs BCYC Comparison
EBF vs BCYC Comparison
Compare EBF & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBF
- BCYC
- Stock Information
- Founded
- EBF 1909
- BCYC 2009
- Country
- EBF United States
- BCYC United Kingdom
- Employees
- EBF N/A
- BCYC N/A
- Industry
- EBF Office Equipment/Supplies/Services
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- EBF Consumer Discretionary
- BCYC Health Care
- Exchange
- EBF Nasdaq
- BCYC Nasdaq
- Market Cap
- EBF 551.3M
- BCYC 587.5M
- IPO Year
- EBF N/A
- BCYC 2019
- Fundamental
- Price
- EBF $19.32
- BCYC $6.81
- Analyst Decision
- EBF
- BCYC Buy
- Analyst Count
- EBF 0
- BCYC 8
- Target Price
- EBF N/A
- BCYC $29.14
- AVG Volume (30 Days)
- EBF 272.2K
- BCYC 354.8K
- Earning Date
- EBF 04-21-2025
- BCYC 05-01-2025
- Dividend Yield
- EBF 5.04%
- BCYC N/A
- EPS Growth
- EBF N/A
- BCYC N/A
- EPS
- EBF 1.58
- BCYC N/A
- Revenue
- EBF $399,351,000.00
- BCYC $35,275,000.00
- Revenue This Year
- EBF N/A
- BCYC N/A
- Revenue Next Year
- EBF N/A
- BCYC $0.27
- P/E Ratio
- EBF $12.80
- BCYC N/A
- Revenue Growth
- EBF N/A
- BCYC 30.76
- 52 Week Low
- EBF $18.88
- BCYC $7.41
- 52 Week High
- EBF $25.75
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- EBF 36.01
- BCYC 25.55
- Support Level
- EBF $19.35
- BCYC $8.60
- Resistance Level
- EBF $20.55
- BCYC $9.69
- Average True Range (ATR)
- EBF 0.46
- BCYC 0.61
- MACD
- EBF -0.07
- BCYC -0.07
- Stochastic Oscillator
- EBF 10.05
- BCYC 0.74
About EBF Ennis Inc.
Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialities, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360º Custom LabelsSM, ColorWorx, Enfusion, among others.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.